ClinicalTrials.govpublic full text
A Pilot Study of Crizotinib in Patients With c-MET Positive Gastric Adenocarcinoma as a Third-line Chemotherapy
c-met positive gastric cancer, met poisitivity is defined as at least half of tumor cells show weak, moderate or high staining, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 894900
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.